ArticleInfection2018
The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011-2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group.
Article in Infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Effects of educational animations using message framing on the appropriate antibiotic use by parents: a randomised, three-armed intervention study.BMC public health · 2025Trial
- Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database.PloS one · 2025Article
- Relationship between hospital surgical volume and the perioperative esophagectomy costs for esophageal cancer: a nationwide administrative claims database study.Esophagus : official journal of the Japan Esophageal Society · 2025Article
- Identifying factors improving the intention to use antibiotics appropriately in children and adults using protection motivation theory.PEC innovation · 2024Article
- The Prevalence of Duplicate Prescription of Oral Antibiotic Drugs in Outpatient Care among People Insured by Corporate Health Insurance Societies in Japan.Healthcare (Basel, Switzerland) · 2024Article
- Relationship between antihypertensive drug use and number of people with high blood pressure in FY 2018: a descriptive epidemiological study based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan open data.Journal of pharmaceutical health care and sciences · 2023Article
- Surveillance of Antimicrobial Prescriptions in Community Pharmacies Located in Tokyo, Japan.Antibiotics (Basel, Switzerland) · 2023Article
- Studies of Health Insurance Claims Data in Japan: A Scoping Review.JMA journal · 2023Article
- Effects of population age structure on parenteral antimicrobial use estimations.Scientific reports · 2023Article
- Prescribed daily-dose-based metrics of oral antibiotic use for hospitalized children in Japan.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Association between Carbapenem Consumption and Clinical Outcomes in an In-Hospital Setting: Analysis of a Japanese Nationwide Administrative Database in 2020.Antibiotics (Basel, Switzerland) · 2022Article
- The consequence of financial incentives for not prescribing antibiotics: a Japan's nationwide quasi-experiment.International journal of epidemiology · 2022Article
- Search for Indexes to Evaluate Trends in Antibiotic Use in the Sub-Prefectural Regions Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.Antibiotics (Basel, Switzerland) · 2022Article
- Exploration of Trends in Antimicrobial Use and Their Determinants Based on Dispensing Information Collected from Pharmacies throughout Japan: A First Report.Antibiotics (Basel, Switzerland) · 2022Article
- Effect of Antimicrobial Stewardship on Oral Quinolone Use and Resistance Patterns over 8 Years (2013-2020).Antibiotics (Basel, Switzerland) · 2021Article
- Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).Antibiotics (Basel, Switzerland) · 2021Review
- Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital.Infection prevention in practice · 2021Article
- Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan.Internal medicine (Tokyo, Japan) · 2021Review
- Article
- Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeOur objective was to evaluate the utility of the national database (NDB) based on health insurance claims data for antimicrobial use (AMU) surveillance in medical institutions in Japan.
methodsThe population-weighted total AMU expressed as defined daily doses (DDDs) per 1000 inhabitants per day (DID) was measured by the NDB. The data were compared with our previous study measured by the sales data. Trend analysis of DID from 2011 to 2013 and subgroup analysis stratified by antimicrobial category and age group were performed.
resultsThere was a significant linear correlation between the AMUs measured by the sales data and the NDB. Total oral and parenteral AMUs (expressed in DID) were 1.04-fold from 12.654 in 2011 to 13.202 in 2013 and 1.13-fold from 0.734 to 0.829, respectively. Percentage of oral form among total AMU was high with more than 94% during the study period. AMU in the children group (0-14 years) decreased from 2011 to 2013 regardless of dosage form, although the working age group (15-64 years) and elderly group (65 and above years) increased. Oral AMU in the working age group was approximately two-thirds of those in the other age groups. In contrast, parenteral AMU in the elderly group was extremely high compared to the other age groups.
conclusionsThe trend of AMU stratified by antimicrobial category and age group were successfully measured using the NDB, which can be a tool to monitor outcome indices for the national action plan on antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.